The Class III Medical Devices that Need to Be Approved for Clinical Trials (Revised in 2020, Draft for Comments)

In order to further strengthen the management of clinical trials of medical devices, safeguard the rights and interests of the subjects in the clinical trials of medical devices, promote the transformation of scientific research results, improve the efficiency of approval, and accelerate the listing of products, the NMPA revised theClass III Medical Devices that Need to Be Approved for Clinical Trials" and drafted theClass III Medical Devices that Need to Be Approved for Clinical Trials (Revised in 2020, draft for comments).

Compared with the products already on the market, medical device products adopt new designs, materials or mechanisms, and/or are applicable to a new scope of application, requires clinical trials in China. In order to protect the rights and interests of clinical trial subjects, those medical devices that require clinical trials in China and have a higher risk to humans should be subject to clinical trial approval. These include the following scenarios:

Contact Us
CIRS China

Mr. Harold Xie (Head office)
Tel: +86-571 8720 6559 | Fax: +86-571 87206533
Email: md@cirs-group.com
Mr. Edwin Wen (Beijing office)
Tel: +86-10 63984062 | Fax: +86-10 63984032
Email: md@cirs-group.com

CIRS Europe

Bryan Zhou
Tel:  +353 (1)477 3710

Email: md@cirs-group.com

CIRS Korea
Mr. Junho Lee 
Tel: +82 2 6347 8801 
Email: md@cirs-group.com